BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 25369805)

  • 1. Carabin protects against cardiac hypertrophy by blocking calcineurin, Ras, and Ca2+/calmodulin-dependent protein kinase II signaling.
    Bisserier M; Berthouze-Duquesnes M; Breckler M; Tortosa F; Fazal L; de Régibus A; Laurent AC; Varin A; Lucas A; Branchereau M; Marck P; Schickel JN; Deloménie C; Cazorla O; Soulas-Sprauel P; Crozatier B; Morel E; Heymes C; Lezoualc'h F
    Circulation; 2015 Jan; 131(4):390-400; discussion 400. PubMed ID: 25369805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
    Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
    Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac-Specific EPI64C Blunts Pressure Overload-Induced Cardiac Hypertrophy.
    Zhu X; Fang J; Gong J; Guo JH; Zhao GN; Ji YX; Liu HY; Wei X; Li H
    Hypertension; 2016 May; 67(5):866-77. PubMed ID: 27021007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epoxyeicosatrienoic acid prevents maladaptive remodeling in pressure overload by targeting calcineurin/NFAT and Smad-7.
    Li X; Chu G; Zhu F; Zheng Z; Wang X; Zhang G; Wang F
    Exp Cell Res; 2020 Jan; 386(1):111716. PubMed ID: 31734152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ryanodine receptor type 2 is required for the development of pressure overload-induced cardiac hypertrophy.
    Zou Y; Liang Y; Gong H; Zhou N; Ma H; Guan A; Sun A; Wang P; Niu Y; Jiang H; Takano H; Toko H; Yao A; Takeshima H; Akazawa H; Shiojima I; Wang Y; Komuro I; Ge J
    Hypertension; 2011 Dec; 58(6):1099-110. PubMed ID: 21986507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac CaM Kinase II genes δ and γ contribute to adverse remodeling but redundantly inhibit calcineurin-induced myocardial hypertrophy.
    Kreusser MM; Lehmann LH; Keranov S; Hoting MO; Oehl U; Kohlhaas M; Reil JC; Neumann K; Schneider MD; Hill JA; Dobrev D; Maack C; Maier LS; Gröne HJ; Katus HA; Olson EN; Backs J
    Circulation; 2014 Oct; 130(15):1262-73. PubMed ID: 25124496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of heterotrimeric G protein and calcium in cardiomyocyte hypertrophy induced by IGF-1.
    Carrasco L; Cea P; Rocco P; Peña-Oyarzún D; Rivera-Mejias P; Sotomayor-Flores C; Quiroga C; Criollo A; Ibarra C; Chiong M; Lavandero S
    J Cell Biochem; 2014 Apr; 115(4):712-20. PubMed ID: 24243530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis.
    Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM
    J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitexin protects against cardiac hypertrophy via inhibiting calcineurin and CaMKII signaling pathways.
    Lu CC; Xu YQ; Wu JC; Hang PZ; Wang Y; Wang C; Wu JW; Qi JC; Zhang Y; Du ZM
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Aug; 386(8):747-55. PubMed ID: 23624753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca²⁺-mediated calcineurin/NFATc3 and CaMKII signaling cascades.
    Dai H; Jia G; Liu X; Liu Z; Wang H
    Environ Toxicol Pharmacol; 2014 Jul; 38(1):263-71. PubMed ID: 24975447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macromolecular Complex Including MLL3, Carabin and Calcineurin Regulates Cardiac Remodeling.
    Pane R; Laib L; Formoso K; Détrait M; Sainte-Marie Y; Bourgailh F; Ruffenach N; Faugeras H; Simon I; Lhuillier E; Lezoualc'h F; Conte C
    Circ Res; 2024 Jan; 134(1):100-113. PubMed ID: 38084599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FKBP12.6 protects heart from AngII-induced hypertrophy through inhibiting Ca
    Xiao YF; Zeng ZX; Guan XH; Wang LF; Wang CJ; Shi H; Shou W; Deng KY; Xin HB
    J Cell Mol Med; 2018 Jul; 22(7):3638-3651. PubMed ID: 29682889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal calcium sensor-1 promotes immature heart function and hypertrophy by enhancing Ca2+ signals.
    Nakamura TY; Jeromin A; Mikoshiba K; Wakabayashi S
    Circ Res; 2011 Aug; 109(5):512-23. PubMed ID: 21737792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitogen-Activated Protein Kinase and Intracellular Polyamine Signaling Is Involved in TRPV1 Activation-Induced Cardiac Hypertrophy.
    Chen M; Xin J; Liu B; Luo L; Li J; Yin W; Li M
    J Am Heart Assoc; 2016 Jul; 5(8):. PubMed ID: 27473037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes.
    Fiedler B; Wollert KC
    Cardiovasc Res; 2004 Aug; 63(3):450-7. PubMed ID: 15276470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice.
    Chiang CS; Huang CH; Chieng H; Chang YT; Chang D; Chen JJ; Chen YC; Chen YH; Shin HS; Campbell KP; Chen CC
    Circ Res; 2009 Feb; 104(4):522-30. PubMed ID: 19122177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caspase recruitment domain 6 protects against cardiac hypertrophy in response to pressure overload.
    Li L; Chen W; Zhu Y; Wang X; Jiang DS; Huang F; Wang L; Xiang F; Qin W; Wang Q; Zhang R; Zhu X; Li H; Chen X
    Hypertension; 2014 Jul; 64(1):94-102. PubMed ID: 24777975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
    Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
    Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of calmodulin induces cardiac hypertrophy by a calcineurin-dependent pathway.
    Obata K; Nagata K; Iwase M; Odashima M; Nagasaka T; Izawa H; Murohara T; Yamada Y; Yokota M
    Biochem Biophys Res Commun; 2005 Dec; 338(2):1299-305. PubMed ID: 16256941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of distinct sources of Ca(2+) on cardiac hypertrophy in cardiomyocytes.
    Xu H; Zhang Y; Sun J; Wei J; Sun L; Zhang J
    Exp Biol Med (Maywood); 2012 Mar; 237(3):271-8. PubMed ID: 22345300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.